ABT-863

N/A

Report date: 2025/06/23 15:39:05
First In Class

Base Information

Drug NameABT-863
Drug Alias NameABT-863
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-C-C chemokine receptor type 8
TargetsC-C chemokine receptor type 8
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbilita Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbilita Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A